Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 1/20 | 0.47 |
| ▸ | TAS1R3 | Q7RTX0 | 7/20 | 0.44 |
| ▸ | TAS1R1 | Q7RTX1 | 7/20 | 0.44 |
| ▸ | TAS1R2 | Q8TE23 | 7/20 | 0.44 |
| ▸ | SPR | P35270 | 2/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CRHBP | P24387 | 1/20 | 0.38 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22281384 | 0.92 | PDE2A (0.48) | PDE2ATAS1R3TAS1R1TAS1R2SPR | |
| SCHEMBL22281280 | 0.90 | PDE2A (0.47) | PDE2ATAS1R3TAS1R1TAS1R2SPR | |
| SCHEMBL22281404 | 0.88 | BRD4 (0.36) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL31171097 | 0.86 | PDE2A (0.48) | PDE2ATAS1R3TAS1R1TAS1R2SPR | |
| SCHEMBL22281279 | 0.86 | TAS1R3 (0.51) | PDE2ATAS1R3TAS1R1TAS1R2ALDH1A1 | |
| SCHEMBL20768156 | 0.85 | PDE2A (0.48) | PDE2ATAS1R3TAS1R1TAS1R2SPR | |
| SCHEMBL20768158 | 0.85 | PDE2A (0.48) | PDE2ATAS1R3TAS1R1TAS1R2SPR | |
| SCHEMBL31171093 | 0.85 | PDE2A (0.48) | PDE2ATAS1R3TAS1R1TAS1R2SPR | |
| SCHEMBL22281223 | 0.81 | NR3C1 (0.35) | PDE2A | |
| SCHEMBL20768127 | 0.81 | PDE2A (0.55) | PDE2ATAS1R3TAS1R1TAS1R2SPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10934301-B2 | Pyrazolopyrimidine derivatives | BAYER ANIMAL HEALTH GMBH (DE) | 2021-03-02 | — | — | US | disclosed |
| US-20200239482-A1 | PYRAZOLOPYRIMIDINE DERIVATIVES | BAYER ANIMAL HEALTH GMBH (DE) | 2020-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200239482-A1 | PYRAZOLOPYRIMIDINE DERIVATIVES | P2RX5, RECQL, P2RX1 | PDE2A 785/4885TAS1R3 2894/4885TAS1R1 2607/4885 |
| US-10934301-B2 | Pyrazolopyrimidine derivatives | P2RX5, RECQL, P2RX1 | PDE2A 785/4885TAS1R3 2894/4885TAS1R1 2607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.